Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 200

1.

Response to Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care".

Vaccaro O, Nicolucci A, Lucisano G, Masulli M, Riccardi G.

J Clin Endocrinol Metab. 2020 Mar 1;105(3). pii: dgz135. doi: 10.1210/clinem/dgz135. No abstract available.

PMID:
32036387
2.

Association between On-Treatment Haemoglobin A1c and All-Cause Mortality in Individuals with Type 2 Diabetes: Importance of Personalized Goals and Type of Anti-Hyperglycaemic Treatment.

Orsi E, Bonora E, Solini A, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Zerbini G, Morano S, Nicolucci A, Penno G, Pugliese G.

J Clin Med. 2020 Jan 17;9(1). pii: E246. doi: 10.3390/jcm9010246.

3.

Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.

Nicolucci A, Ceriello A, Di Bartolo P, Corcos A, Orsini Federici M.

Diabetes Ther. 2020 Mar;11(3):573-584. doi: 10.1007/s13300-019-00732-w. Epub 2019 Dec 23. Review.

4.

Weekend-Based Parent-Group Intervention to Reduce Stress in Parents of Children and Adolescents with Type 1 Diabetes: A Pilot Study.

Ferrito L, Predieri B, Pjetraj D, Alessandrelli MC, Pagnini M, Iannilli A, Marino M, Tombolini S, Pintaudi B, Lucisano G, Zani F, Iughetti L, Nicolucci A, Cherubini V.

J Diabetes Res. 2019 Nov 29;2019:7935945. doi: 10.1155/2019/7935945. eCollection 2019.

5.

Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study.

Heerspink HJL, Karasik A, Thuresson M, Melzer-Cohen C, Chodick G, Khunti K, Wilding JPH, Garcia Rodriguez LA, Cea-Soriano L, Kohsaka S, Nicolucci A, Lucisano G, Lin FJ, Wang CY, Wittbrodt E, Fenici P, Kosiborod M.

Lancet Diabetes Endocrinol. 2020 Jan;8(1):27-35. doi: 10.1016/S2213-8587(19)30384-5.

PMID:
31862149
6.

Erratum. Overall Quality of Care Predicts the Variability of Key Risk Factors for Complications in Type 2 Diabetes: An Observational, Longitudinal Retrospective Study. Diabetes Care 2019;42:514-519.

Ceriello A, Rossi MC, De Cosmo S, Lucisano G, Pontremoli R, Fioretto P, Giorda C, Pacilli A, Viazzi F, Russo G, Nicolucci A; AMD-Annals Study Group.

Diabetes Care. 2020 Feb;43(2):497. doi: 10.2337/dc20-er02. Epub 2019 Dec 11. No abstract available.

7.

INtegration of care for reaching targetS In Diabetic patiEnts: Design of the INSIDE Study.

Comaschi M, Di Lenarda A, Medea G, Aglialoro A, Cucinotta D, Gulizia M, Vespasiani G, Zuin G, Nicolucci A, Spandonaro F, Maggioni AP.

Diabetes Ther. 2020 Jan;11(1):359-367. doi: 10.1007/s13300-019-00731-x. Epub 2019 Nov 22.

8.

Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention.

Nusca A, Tuccinardi D, Proscia C, Melfi R, Manfrini S, Nicolucci A, Ceriello A, Pozzilli P, Ussia GP, Grigioni F, Di Sciascio G.

Cardiovasc Diabetol. 2019 Nov 9;18(1):147. doi: 10.1186/s12933-019-0952-8.

9.

Penetration force and cannula sliding profiles of different pen needles: the PICASSO study.

Leonardi L, Viganò M, Nicolucci A.

Med Devices (Auckl). 2019 Aug 28;12:311-317. doi: 10.2147/MDER.S218983. eCollection 2019. Erratum in: Med Devices (Auckl). 2019 Nov 08;12:459.

10.

Study to Weigh the Effect of Exercise Training on BONE quality and strength (SWEET BONE) in type 2 diabetes: study protocol for a randomised clinical trial.

Balducci S, Conti F, Sacchetti M, Russo CR, Argento G, Haxhi J, Orlando G, Rapisarda G, D'Errico V, Cardelli P, Pugliese L, Laghi A, Vitale M, Bollanti L, Zanuso S, Nicolucci A, Pugliese G; SWEET BONE Investigators.

BMJ Open. 2019 Nov 4;9(11):e027429. doi: 10.1136/bmjopen-2018-027429.

11.

Intensive Glucose Control and Type 2 Diabetes - 15 Years On.

Ceriello A, Nicolucci A.

N Engl J Med. 2019 Sep 26;381(13):1292-1293. doi: 10.1056/NEJMc1909041. No abstract available.

PMID:
31553849
12.

Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme.

Khunti K, Chen H, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Ji L, Kosiborod M, Pocock S, Shestakova MV, Shimomura I, Tang F, Watada H, Nicolucci A; DISCOVER investigators.

Diabetes Obes Metab. 2020 Jan;22(1):66-78. doi: 10.1111/dom.13866. Epub 2019 Oct 1.

13.

Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice.

Nicolucci A, Candido R, Cucinotta D, Graziano G, Rocca A, Rossi MC, Tuccinardi F, Manicardi V.

Adv Ther. 2019 Oct;36(10):2895-2909. doi: 10.1007/s12325-019-01043-z. Epub 2019 Aug 13.

PMID:
31410779
14.

Budget Impact of Improved Diabetes Management by Utilization of Glucose Meters With a Color-Range Indicator-Comparison of Five European Healthcare Systems.

Fritzen K, Basinska K, Stautner C, Braun KF, Rubio-Almanza M, Nicolucci A, Kennon B, Vergès B, Hosny Y, Schnell O.

J Diabetes Sci Technol. 2020 Mar;14(2):262-270. doi: 10.1177/1932296819864665. Epub 2019 Aug 6.

PMID:
31387385
15.

Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme.

Nicolucci A, Charbonnel B, Gomes MB, Khunti K, Kosiborod M, Shestakova MV, Shimomura I, Watada H, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Surmont F, Tang F, Pocock S.

Diabetes Obes Metab. 2019 Nov;21(11):2474-2485. doi: 10.1111/dom.13830. Epub 2019 Aug 5.

16.

Control of Gram-negative multi-drug resistant microorganisms in an Italian ICU: Rapid decline as a result of a multifaceted intervention, including conservative use of antibiotics.

Frattari A, Savini V, Polilli E, Di Marco G, Lucisano G, Corridoni S, Spina T, Costantini A, Nicolucci A, Fazii P, Viale P, Parruti G.

Int J Infect Dis. 2019 Jul;84:153-162. doi: 10.1016/j.ijid.2019.04.002.

17.

Incidence of severe hypoglycemia and possible associated factors in pediatric patients with type 1 diabetes in the real-life, post-Diabetes Control and Complications Trial setting: A systematic review.

Cherubini V, Rabbone I, Lombardo F, Mossetto G, Orsini Federici M, Nicolucci A.

Pediatr Diabetes. 2019 Sep;20(6):678-692. doi: 10.1111/pedi.12876. Epub 2019 Jun 30.

PMID:
31177592
18.

Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study.

Rossi MC, Nicolucci A, Ozzello A, Gentile S, Aglialoro A, Chiambretti A, Baccetti F, Gentile FM, Romeo F, Lucisano G, Giorda CB; HYPOS-1 Study Group of AMD.

Nutr Metab Cardiovasc Dis. 2019 Jul;29(7):736-743. doi: 10.1016/j.numecd.2019.04.009. Epub 2019 May 6.

PMID:
31153746
19.

Urban diabetes: the case of the metropolitan area of Rome.

Nicolucci A, Rossi MC, Vaccaro K, Crialesi R, Rossetti S, Da Empoli S, Corsaro L, Morviducci L, Baroni MG, Frontoni S, Dotta F.

Acta Biomed. 2019 May 23;90(2):209-214. doi: 10.23750/abm.v90i2.8345. Review.

20.

Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care.

Vaccaro O, Lucisano G, Masulli M, Bonora E, Del Prato S, Rivellese AA, Giorda CB, Mocarelli P, Squatrito S, Maggioni AP, Riccardi G, Nicolucci A; TOSCA.IT Investigators.

J Clin Endocrinol Metab. 2019 Aug 1;104(8):3296-3302. doi: 10.1210/jc.2019-00361.

PMID:
31058962

Supplemental Content

Loading ...
Support Center